Julia Lainster

The emergence of chimeric antigen receptor T-cell therapy has revolutionized the oncological landscape by providing a potent "living drug" that can hunt and destroy malignant cells, yet nearly half of all patients still experience clinical relapses that threaten the long-term viability of this

The journey of a life-saving injectable molecule often begins with a deceptive sense of simplicity on a laboratory bench, only to face an unforgiving reality when moved toward large-scale clinical manufacturing. While the ambition to reach in-human trials quickly is a common driver for drug owners,

The field of neurotechnology is currently witnessing a transformative shift as we move away from static, "one-size-fits-all" medical devices toward intelligent, responsive systems. For decades, deep brain stimulation has been a cornerstone in treating the motor symptoms of Parkinson's disease, but

The rapid democratization of home genome sequencing has transformed millions of private living rooms into makeshift laboratories where individuals voluntarily trade their most intimate biological data for digital snapshots of their ancestry and health predispositions. While the convenience of these

Ivan Kairatov is a leading voice in biopharmaceutical innovation, bringing years of experience in metabolic research and the development of disruptive medical technologies. In this discussion, we explore the recent landmark approval of an oral semaglutide tablet by the UK’s Medicines and Healthcare

The shift toward perceiving oncological pathologies as dynamic ecological systems has fundamentally altered the trajectory of modern clinical intervention and therapeutic research. Recent breakthroughs led by specialized teams at Peking University have moved the medical community away from the

The healthcare sector is currently navigating a period where medical devices no longer exist as rigid hardware units but as fluid software entities capable of altering their internal logic based on new data. This technological evolution has outpaced the federal oversight mechanisms originally

The precision required for modern robotic-assisted surgery has reached a threshold where traditional component-matching methods often fail to meet the rigorous demands of next-generation clinical environments. Engineers now face the daunting task of cramming more power and intelligence into

The ability to reprogram living organisms to produce high-value chemicals and materials has transitioned from a niche academic pursuit to the cornerstone of a new economic paradigm. Instead of relying on the extraction of finite fossil fuels, industries are increasingly looking toward the

The industrial foundation of Europe's largest economy is trembling as the pharmaceutical sector, once a cornerstone of German innovation, signals a deep-seated retreat from the domestic market. For decades, the nation was celebrated as the "pharmacy of the world," but a series of aggressive